Details for New Drug Application (NDA): 018128
✉ Email this page to a colleague
NDA 018128 describes OVCON-50, which is a drug marketed by Warner Chilcott and Warner Chilcott Llc and is included in two NDAs. Additional details are available on the OVCON-50 profile page.
The generic ingredient in OVCON-50 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in OVCON-50 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 018128
| Tradename: | OVCON-50 |
| Applicant: | Warner Chilcott |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.05MG;1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
